Asthma
📧 Sign up to get email alerts when something new happens for Asthma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-02-09Clinical Trial Update: Disclosure of Smoking in Adolescents With Asthma [NA]
An update on a clinical trial investigating smoking disclosure among adolescents with asthma, sponsored by Imperial College London; current …
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Study of the Ease of Use and Correct Use of Placebo ELLIPTA® Inhaler in Subjects With Asthma [Phase 4]
Phase 4 study evaluating the ease of use and correct use of the Ellipta inhaler with placebo in adults with asthma. Results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Acute Effect of Salbutamol on Heart Rate and Blood Pressure During Exercise in Patients With Moderate or Severe Asthma and Healthy Subjects [Phase 4]
Phase 4 clinical trial evaluating the acute effects of inhaled salbutamol on heart rate and blood pressure during exercise in adults with mo…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Montelukast for Early Life Wheezing [Phase 2, Phase 3]
Montelukast has completed Phase 2 and Phase 3 trials for early-life wheezing; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Safety and Efficacy Study of Adding GSK2190915 to Low Dose Inhaled Corticosteroid Treatment for Asthma Subjects > or = 12 Years of Age [Phase 2]
Phase 2 trial update assessing safety and efficacy of adding GSK2190915 to low-dose inhaled corticosteroid therapy in asthma patients aged 1…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: A Randomized Study Evaluating Steroid Hormone Levels, Safety And Tolerability Of GW870086X In Healthy Volunteers [Phase 1]
A Phase 1 randomized study assessed steroid hormone levels, safety, and tolerability of GW870086X in healthy volunteers; the study has been …
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate [Phase 4]
A Phase 4 study in asthma patients comparing the combination inhaler Fluticasone Propionate/Salmeterol with Salmeterol Xinafoate, examining …
-
CLINICAL_TRIALS research · 2017-02-03Clinical Trial Update: Salbutamol in the Pediatric Emergencies: Nebulization Estimated Via AerogeN or Jet [NA]
Update on a pediatric asthma trial evaluating nebulized salbutamol delivered via Aerogen or Jet nebulizers; current status is Unknown.
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Using Computers to Assist in the Treatment of Asthma in a Pediatric Setting [NA]
The trial evaluated computer-assisted treatment in pediatric asthma. It has completed, and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Efficacy of the PARI LC Sprint Sp Nebulizer for Acute Asthma Attack in Hospitalized Children Less Than 36 Months of Age [NA]
The trial update reports on the efficacy of the PARI LC Sprint Sp Nebulizer for acute asthma attacks in hospitalized children under 36 month…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: The Effect of an AEP on Patient's Knowledge Regarding Asthma Disease and Inhaler Technique: RCT [NA]
A randomized controlled trial evaluating whether an asthma education program (AEP) improves patients' knowledge of asthma and inhaler techni…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Aerosol Delivery in Different Types of Nebulizers [NA]
The clinical trial update notes the completion of a study comparing aerosol delivery across different nebulizer types in individuals with as…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: A Study to Assess the Efficacy, Safety, and Tolerability of CAT-354 in Subjects With Asthma [Phase 2]
Phase 2 study evaluating the efficacy, safety, and tolerability of CAT-354 in subjects with asthma was terminated, with results posted in 20…
-
EMA withdrawal · 2017-01-31EMA Withdrawn: Budesonide/Formoterol Teva (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
EMA confirms withdrawal of Budesonide/Formoterol Teva, a combination inhaled therapy, from the product market.
-
FDA approval · 2017-01-31FDA Approved: LEVALBUTEROL — Original Application (Aurobindo Pharma Limited)
The FDA approved an original ANDA for Levalbuterol from Aurobindo Pharma Limited, providing a generic option for this bronchodilator.
-
EMA withdrawal · 2017-01-30EMA Withdrawn: Budesonide/Formoterol Teva Pharma B.V. (Budesonide;formoterol) — Teva Pharma B.V.
The EMA withdrew the Budesonide/Formoterol Teva Pharma B.V. product, a combination therapy for asthma, from its marketing authorization.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: House Dust Mite Treatment of Asthma. The MITRA Trial House Dust Mite Treatment of Asthma [Phase 3]
The MITRA trial, a Phase 3 study evaluating house dust mite immunotherapy for asthma, has completed. The sponsor is ALK-Abelló A/S.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Mobile Technology and Online Tools to Improve Asthma Control in Adolescents - Usability [NA]
A completed usability study evaluating mobile technology and online tools designed to improve asthma control in adolescents.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies [Phase 2]
A phase 2 study evaluating the safety and pharmacodynamics of repeat intranasal dosing of the TLR7 agonist GSK2245035 in subjects with asthm…
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: Telephone-Based Program to Promote Inhaled Corticosteroid Adherence Among Individuals With Asthma [NA]
A completed clinical trial evaluated a telephone-based program to promote adherence to inhaled corticosteroids in people with asthma; result…
-
FDA approval · 2017-01-27FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's Fluticasone Propionate and Salmeterol under an Original Application (NDA208799), a fixed-dose inhaled corticosteroid/lon…
-
FDA approval · 2017-01-27FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for budesonide and formoterol fumarate dihydrate to update the product labeling for AstraZeneca's in…
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: The Effects of Broccoli Sprout Extract on Obstructive Lung Disease [NA]
A Johns Hopkins University clinical trial evaluated broccoli sprout extract for obstructive lung diseases (asthma and chronic obstructive pu…
-
EMA withdrawal · 2017-01-26EMA Withdrawn: Vylaer Spiromax (Budesonide;formoterol fumarate dihydrate) — Teva Pharma B.V.
The EMA has withdrawn Vylaer Spiromax (budesonide/formoterol) from the market in the EU.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist [Phase 3]
This document reports the completion and results of a Phase 3 efficacy and safety study of benralizumab in adults and adolescents with asthm…